Sensus Healthcare, Inc. announces management promotions to better support the company's financial goals for profitability in 2020 and beyond. Key changes, which are effective immediately, include: The promotion of Russ Price to Chief Technology Officer. The promotion of Javier Rampolla to Chief Financial Officer.

The promotion of Nicolas Soro to the newly created position of Chief Operating Officer. All will report directly to Joe Sardano, Sensus Healthcare's chairman and chief executive officer. Russ Price joined Sensus in 2016 as a product manager.

He has more than 20 years of experience in the PET and Molecular Imaging field in varying roles, including the engineering for cyclotrons and scanners, national service manager, applications manager and product manager. Javier Rampolla has been director of accounting and reporting/controller at Sensus since 2015 and has more than 20 years of financial experience, holding positions of increasing responsibility at a number of public and private companies. He played an important role in managing the company's initial public offering in June 2016 and worked to apply new U.S. GAAP guidelines for revenue recognition and leases.

Nicolas Soro has been director of regulatory affairs and quality assurance at Sensus from 2016. His work included the development of new devices, including obtaining multiple 510(k) clearances from the U.S. Food and Drug Administration (FDA), including for Sculptura and the software (Sentinel) for treatment planning contained in the SRT-100 Vision and SRT-100 Plus. Prior to Sensus, Mr. Soro was director of regulatory affairs and quality assurance at DemeTECH Corporation, based in Miami, from 2011 to 2016, joining DemeTECH in 2009 as manager of regulatory affairs and quality assurance.